jili super ace tricks 。

Amaravati: YSR Congress Party leader and former IAS officer Mohammed Imtiaz on Friday bid goodbye to politics. Imtiaz, who had taken voluntary retirement from service to join the YSR Congress Party (YSRCP), announced that he was quitting politics due to personal reasons. On the invitation of then ruling party YSRCP, Imtiaz had taken voluntary retirement and joined the party in February this year. YSRCP President and then Chief Minister Y. S. Jagan Mohan Reddy had picked Imtiaz as the party candidate from the Kurnool constituency in Assembly elections held in May, denying renomination to sitting MLA Hafeez Khan. The former bureaucrat, however, lost to Telugu Desam Party’s T. G. Bharath by a margin of 18,876 votes. As the YSRCP lost power, Imtiaz apparently saw no future for himself in the party and decided to quit. Several leaders including three Rajya Sabha members have quit the YSRCP since the TDP-Jana Sena-BJP alliance stormed to power with a landslide victory in the May 13 elections. The alliance bagged 164 out of 175 Assembly seats and it also won 21 out of 25 Lok Sabha seats. The YSRCP, which had come to power in 2019 by winning 151 Assembly seats, could win only 11 seats. The party managed to win only four out of 25 Lok Sabha seats in the state. Mopidevi Venkatramna, B. Mastan Rao, and R. Krishnaiah resigned from their Rajya Sabha membership and also the YSRCP in September. Venkatramna and Mastan Rao joined the TDP, which recently nominated Mastan Rao to Rajya Sabha. The BJP sent Krishnaiah once again to the upper house of the Parliament. Former minister Avanthi Srinivas resigned from the YSRCP on December 12. He resigned both as YSRCP in-charge for the Bheemili Assembly constituency and from the primary membership of the party. In his resignation letter to YSRCP President Jagan Mohan Reddy and party’s North Andhra coordinator Vijayasai Reddy, Srinivas mentioned that he would like to distance himself from politics for personal reasons.Clearmind Medicine Inc. CMND saw its shares rise on Tuesday after announcing that it has received Institutional Review Board (IRB) approval for its Phase I/IIa clinical trial of CMND-100, a drug targeting alcohol use disorder (AUD) . This approval marks a significant milestone in the company’s FDA-regulated clinical program, and the trial will be conducted at Yale School of Medicine’s Department of Psychiatry, led by Anahita Bassir Nia , an expert in psychiatry and addiction medicine. The trial will evaluate the safety, tolerability, and efficacy of CMND-100, a proprietary investigational drug designed to reduce alcohol cravings and consumption in individuals with moderate to severe AUD. Adi Zuloff-Shani , CEO of Clearmind Medicine, emphasized the importance of this step, noting that alcohol use is a leading preventable cause of death globally, responsible for 2.6 million deaths annually. Also Read: What’s Going On With NIO Stock On Tuesday? Current treatment options are limited, with low efficacy and patient compliance. Clearmind aims to address this gap with CMND-100, offering a potential solution for treating AUD that could significantly improve patient outcomes. The trial is expected to provide critical data to support the advancement of CMND-100 through its clinical pipeline, offering hope for more effective treatment options for those struggling with alcohol addiction. According to Benzinga Pro , CMND stock has lost over 6% in the past month. Investors can gain exposure to the stock via AdvisorShares Psychedelics ETF PSIL . Price Action: CMND shares are trading higher by 35% to $1.64 at last check Tuesday. Read Action: Bitcoin Flat, Ethereum, Dogecoin Spike Ahead Of Christmas: Analyst Says Decline In BTC Dominance Leaves ‘Room For Altcoins To Pick Up' Photo: Shutterstock This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.The Chicago Blackhawks face the Buffalo Sabres on Friday, Dec. 27, 2024 (12/27/24) in a regular season game at KeyBank Center in Buffalo, N.Y. How to watch: Fans can watch the game for free via a trial of DirecTV Stream or fuboTV . You can also watch via a subscription to Sling TV , which is offering half off your first month. — DirecTV Stream is offering $30 off on Entertainment with Sports Pack featuring NFL RedZone, BIG Ten Network and more. — Sling TV is offering plans for as low as $20 for your first month Here’s what you need to know: What : NHL regular season Who : Blackhawks vs. Sabres When : Dec. 27, 2024 (12/27/24) Time : 7 p.m. ET Where : KeyBank Center TV : ESPN2 Live stream : DirecTV Stream (free trial), fuboTV (free trial) *** Here’s an NHL story via the Associated Press: NEW YORK (AP) — The NHL is partnering with P-X-P to serve the Deaf community, creating an alternate telecast for the Winter Classic that features analysis in American Sign Language. The announcement was made by the league and a company that aims to improve access to ASL in sports. NHL in ASL made its debut when Florida outlasted Edmonton in the 2024 Stanley Cup Final, showing two deaf commentators signing during a game for the first time during a major sports event. The groundbreaking concept will return — streaming on Max in the United States and Sportsnet+ in Canada — on Dec. 31 when the Chicago Blackhawks and St. Louis Blues play at Wrigley Field. “We are proud to continue to demonstrate the league’s commitment to providing a fully immersive and accessible viewing experience that specifically meets the needs of the Deaf community,” said Steve Mayer , the NHL’s chief content officer. “This is an NHL-led production for the Deaf by the Deaf, and we encourage all fans watching at home to tune-in to experience this special telecast.” Hearing commentators are not heard during the NHL ASL broadcasts, which does include natural sound that would be heard in the arena, such as the officials calling a penalty and skates cutting through ice. Graphics such as a crowd intensity meter that measures crowd noise are also shown. Closed captioning has been around for more than four decades, but the boxes of text in English do not provide true access to viewers in the Deaf community . P-X-P chief operating officer Jason Altmann and Noah Blankenship from Denver’s Office of Deaf and Hard of Hearing Services will appear on the right side of a split screen during the Winter Classic, just as they did for seven games during the Cup Final. “The NHL continues to be a sports industry pioneer for Deaf inclusion and accessibility and I am honored to be part of this game-changing initiative,” Altmann said. (The Associated Press contributed to this report) Thank you for relying on us to provide the journalism you can trust. Please consider supporting us with a subscription.ABU DHABI, (UrduPoint / Pakistan Point News / WAM - 25th Dec, 2024) SEHA, a subsidiary of PureHealth, successfully performed an Extracorporeal Cardiopulmonary Resuscitation (ECPR) on a 39-year-old at Sheikh Khalifa Medical City (SKMC). This case underscores SEHA's dedication to employing advanced medical technologies and procedures for patient-centred interventions, thereby setting new standards in emergency medical care. The patient, a previously healthy individual, presented to SKMC with progressive shortness of breath and severe hypoxia, showing a markedly low oxygen saturation of only 60 percent on room air and a heart rate exceeding 150 beats per minute. A bedside ECHO quickly revealed right ventricular heart strain, which could signify the presence of a massive pulmonary embolism, a fatal diagnosis. This led to the consideration of ECMO in anticipation of a rapid irreversible deterioration. A massive saddle pulmonary embolism was confirmed via CT scan. Shortly after the CT scan the patient went into cardiac arrest, ECPR was initiated within 15 minutes, proving critical in his subsequent recovery. Extracorporeal cardiopulmonary resuscitation (ECPR) is a salvage procedure in which ECMO is initiated emergently on patients who had cardiac arrest and on whom the conventional cardiopulmonary resuscitation has failed. Post-ECMO, the patient underwent a successful mechanical thrombectomy in the interventional radiology suite and was discharged only nine days later, with full recovery. This successful case highlights the importance of the prompt and coordinated medical intervention and exemplifies the high level of patient care provided by over 20 dedicated healthcare professionals at SKMC. It underscores SEHA’s mission to transform healthcare through a commitment to the highest standards of patient care, thereby enhancing community health outcomes. Dr Ismail Mohamed Al Ramahi, Division Chief of Emergency Medicine at SKMC, said, “This case represents a significant breakthrough in emergency medical care in the and exemplifies SEHA’s commitment to enhancing healthcare through cutting-edge medical interventions and coordinated care. We are proud of the exceptional teamwork and rapid response that enabled us to successfully perform ECPR in the emergency department.” Dr Mohammed Shalaby the Adult ECMO programme director in SKMC, said, ‘Witnessing your dream materialise is indeed the ultimate joy. Implementing ECPR in the emergency department signifies the culmination of immense dedication and the creation of a resilient ECMO program, showcasing a dedication to enhancing critical care and preserving lives.” This case not only showcases SEHA’s expertise in managing acute medical emergencies but also highlights the ’s dedication to integrating innovative medical techniques to save lives. PureHealth's significant investment in across its subsidiaries, including SEHA, ensures that residents across receive top-tier healthcare services, enabling them to longer, healthier, and happier lives.

Resiquimod by SURGE Therapeutics for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of ApprovalNone

ITV I'm A Celeb star reveals they were left with plastic nose after brutal injury